20 September 2023
: Case report 
Eosinophilic Granulomatosis with Polyangiitis Presenting as Steroid-Responsive Sclerosing Cholangitis and Cholecystitis: A Rare Case Report
Unusual clinical course
Yuhei Fujisawa
1BCDEF*, Yukihiro Shirota 2EF, Tokio Wakabayashi2EF
DOI: 10.12659/AJCR.940990
Am J Case Rep 2023; 24:e940990
Table 1. Laboratory data of patients on admission.
| Normal range | ||
|---|---|---|
| Protein | – | – |
| Occult blood | – | – |
| White blood cells (/μL) | 23,540 | 3,500–9,000 |
| Eosinophil (%) | 69 | 0.0–7.0 |
| Hemoglobin (g/dL) | 15.4 | 11.2–15.2 |
| Platelets (×10/μL) | 29.3 | 14.0–37.9 |
| Total protein (g/dL) | 7.7 | 6.5–8.2 |
| Albumin (g/dL) | 3.0 | 3.7–5.5 |
| Aspartate aminotransferase (U/L) | 52 | 10–40 |
| Alanine aminotransferase (U/L) | 72 | 5–45 |
| Alkaline phosphatase (U/L) | 684 | 104–338 |
| Lactate dehydrogenase (U/L) | 289 | 120–245 |
| Gamma-glutamyl transpeptidase (U/L) | 64 | 0–79 |
| Sodium (mEq/L) | 140 | 135–145 |
| Potassium (mEq/L) | 4.2 | 3.5–5.0 |
| Chloride (mEq/L) | 102 | 98–108 |
| Urea nitrogen(mg/dL) | 12.9 | 8.0–20.0 |
| Creatinine (mg/dL) | 0.81 | 0.65–1.09 |
| C-reactive protein (mg/dL) | 2.1 | 0.00–0.30 |
| Immunoglobulin G (mg/dL) | 1862 | 820–1,740 |
| Immunoglobulin A (mg/dL) | 236 | 90–400 |
| Immunoglobulin M (mg/dL) | 72 | 52–270 |
| Immunoglobulin E (U/mL) | 66 | <170 |
| Immunoglobulin G4 (mg/dL) | 452 | 11–121 |
| C3 (mg/dL) | 161 | 80–140 |
| C4 (mg/dL) | 37 | 11.0–34.0 |
| CH50 (U/mL) | 56 | 30–45 |
| Anti-nuclear antibody | ×40 | - |
| Rheumatoid factor (U/mL) | 122 | <15 |
| MPO-ANCA | - | - |
| PR3-ANCA | - | - |
| MPO-ANCA – myeloperoxidase-anti-neutrophil cytoplasmic antibodies; PR3-ANCA – proteinase-3-anti-neutrophil cytoplasmic antibodies. | ||